SANA Q3 2023 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$2M

Net Income

$984,000

EPS (Diluted)

$0.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$66M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$631M

Total Liabilities

$266M

Stockholders' Equity

$366M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$2M	-$86M	+97.5%
Net Income	$984,000	-$85M	+101.2%